X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
enzalutamide (778) 778
prostate cancer (625) 625
index medicus (617) 617
humans (541) 541
male (526) 526
oncology (382) 382
abiraterone (378) 378
prostatic neoplasms, castration-resistant - drug therapy (302) 302
androgen receptor (298) 298
increased survival (279) 279
docetaxel (264) 264
chemotherapy (259) 259
metastasis (241) 241
abiraterone acetate (238) 238
urology & nephrology (233) 233
cancer (228) 228
phenylthiohydantoin - analogs & derivatives (226) 226
androgens (203) 203
prostatic neoplasms, castration-resistant - pathology (184) 184
castration (177) 177
prostate (167) 167
receptors, androgen - metabolism (159) 159
castration-resistant prostate cancer (153) 153
care and treatment (147) 147
cell line, tumor (141) 141
aged (140) 140
animals (136) 136
resistance (134) 134
antitumor-activity (133) 133
treatment outcome (132) 132
receptors, androgen - genetics (130) 130
middle aged (129) 129
survival (128) 128
antineoplastic agents - therapeutic use (120) 120
therapy (120) 120
expression (119) 119
phenylthiohydantoin - therapeutic use (119) 119
progression (115) 115
cabazitaxel (106) 106
drug resistance, neoplasm (105) 105
prostatic neoplasms - drug therapy (105) 105
analysis (101) 101
prednisone (101) 101
article (99) 99
men (97) 97
mitoxantrone (96) 96
double-blind (94) 94
prostatic neoplasms, castration-resistant - metabolism (93) 93
prostatic neoplasms, castration-resistant - genetics (91) 91
phenylthiohydantoin - pharmacology (90) 90
prostatic neoplasms - pathology (90) 90
splice variants (89) 89
research (88) 88
aged, 80 and over (87) 87
urology (86) 86
antiandrogen (84) 84
androgen antagonists - therapeutic use (83) 83
cancer therapies (83) 83
drug therapy (81) 81
development and progression (80) 80
disease progression (79) 79
endocrinology & metabolism (77) 77
cell biology (76) 76
metastases (76) 76
mice (76) 76
neoplasm metastasis (76) 76
disease-free survival (74) 74
retrospective studies (70) 70
ar-v7 (68) 68
tumors (68) 68
health aspects (66) 66
taxoids - therapeutic use (66) 66
urologic and male genital diseases (66) 66
patients (65) 65
antineoplastic agents - pharmacology (64) 64
clinical activity (64) 64
gene expression (64) 64
prognosis (64) 64
drug resistance (63) 63
mutation (63) 63
prostatic neoplasms, castration-resistant - blood (63) 63
prostate-specific antigen - blood (61) 61
inhibition (59) 59
prostatic neoplasms - metabolism (59) 59
medicine & public health (58) 58
signal transduction - drug effects (58) 58
genetic aspects (57) 57
antineoplastic combined chemotherapy protocols - therapeutic use (56) 56
pharmacology & pharmacy (55) 55
cells (54) 54
enzalutamide resistance (54) 54
metastatic castration-resistant prostate cancer (52) 52
mitoxantrone plus prednisone (52) 52
prostatic neoplasms, castration-resistant - mortality (51) 51
alternative splicing (50) 50
growth (50) 50
plus prednisone (50) 50
survival analysis (50) 50
mechanisms (49) 49
apoptosis (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (837) 837
German (20) 20
French (13) 13
Spanish (7) 7
Czech (1) 1
Hungarian (1) 1
Japanese (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 09/2015, Volume 349, Issue 6254, pp. 1351 - 1356
Journal Article
Journal Article
Endocrine-related cancer, ISSN 1351-0088, 11/2018, Volume 25, Issue 11, pp. R545 - R557
Prostate cancer (PCa) is among the most common adult malignancies, and the second leading cause of cancer-related death in men. As PCa is hormone dependent,... 
autophagy | glycolysis | AKR3C1 | IL-6 | resistance | mCRPC | prostate cancer | abiraterone | androgen receptor | hexosamine biosynthesis | mutations | cancer | Wnt | enzalutamide | GLUCOCORTICOID-RECEPTOR | ENDOCRINOLOGY & METABOLISM | O-GLCNAC | UP-REGULATION | DNA-BINDING | INCREASED EXPRESSION | LINEAGE PLASTICITY | NEUROENDOCRINE DIFFERENTIATION | CONFER RESISTANCE | ONCOLOGY | PROSTATE-CANCER CELLS | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2015, Volume 21, Issue 10, pp. 2315 - 2324
Journal Article
International Journal of Oncology, ISSN 1019-6439, 07/2018, Volume 53, Issue 1, pp. 99 - 112
Castration-resistant prostate cancer (CRPC) continues to be a major challenge in the treatment of prostate cancer (PCa). The expression of hepatocyte cell... 
Castration-resistant prostate cancer | PF-3084014 | Hepatocyte cell adhesion molecule | Enzalutamide | Notch signaling | Docetaxel | TARGETED THERAPY | ANDROGEN RECEPTOR | CARCINOMA CELLS | PANCREATIC-CANCER | 3D CULTURE | CROSS-RESISTANCE | castration-resistant prostate cancer | DEPENDENT PATHWAY | BREAST-CANCER | ADHESION MOLECULE | ONCOLOGY | docetaxel | hepatocyte cell adhesion molecule | EXPRESSION | enzalutamide | Phenylthiohydantoin - adverse effects | Humans | Middle Aged | Male | Receptors, Notch - genetics | Valine - administration & dosage | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Prostate - pathology | Receptors, Notch - antagonists & inhibitors | Tetrahydronaphthalenes - administration & dosage | Prostate - drug effects | Adult | Taxoids - adverse effects | Valine - analogs & derivatives | Prostatic Neoplasms, Castration-Resistant - drug therapy | Phenylthiohydantoin - analogs & derivatives | Proteins - genetics | Xenograft Model Antitumor Assays | Disease-Free Survival | Phenylthiohydantoin - administration & dosage | Taxoids - administration & dosage | Drug Resistance, Neoplasm - genetics | Signal Transduction - drug effects | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Care and treatment | Development and progression | Tumor suppressor genes | Genetic aspects | Gene expression | Drug resistance | Prostate cancer | Health aspects | Antigens | Androgens | Metastasis | Cancer therapies | Apoptosis
Journal Article
Journal Article
Journal Article
CANCER RESEARCH, ISSN 0008-5472, 06/2018, Volume 78, Issue 12, pp. 3147 - 3162
Journal Article
Current Drug Targets, ISSN 1389-4501, 2018, Volume 19, Issue 6, pp. 613 - 620
Journal Article
Journal Article